Current status:
Cancelled (Unreturned Annual)
Current status date:
2021-12-20
DIN:
02391708
Electronic product monograph is not available
Company:
EXIR PHARMA INC
70 Silton Road, Unit 18
Woodbridge
Ontario
Canada
L4L 8B9
Dosage form(s):
Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Anatomical Therapeutic Chemical (ATC):
See footnote 4
N02BE01 ACETAMINOPHEN (PARACETAMOL)
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ACETAMINOPHEN
|
160 MG / 5 ML
|